Categories
Change Password!
Reset Password!
Tranexamic acid effectively reduces pain and blood loss in patients undergoing shoulder surgery.
In a comprehensive study encompassing the latest randomized controlled trials (RCTs), researchers have shed new light on the remarkable efficacy and safety of Tranexamic acid (TXA) in shoulder surgery. While TXA has long been established for its blood loss reduction benefits in lower limb arthroplasty, this study delved into its impact on shoulder surgical procedures. The research team meticulously conducted a systematic review and meta-analysis, examining all available RCTs.
A thorough search of major databases, encompassing MEDLINE, CENTRAL, PUBMED, and EMBASE was carried out to explore pertinent studies. Out of the 14 studies scrutinized, encompassing a cohort of 1131 patients, the findings painted a compelling picture of TXA's positive influence on various surgical parameters. The key results included:
In conclusion, the administration of TXA in shoulder surgery emerged as a safe and effective strategy for minimizing blood loss. The study's findings provided a solid foundation for considering TXA as a valuable adjunct in shoulder surgical procedures, promising improved outcomes without significant complications. This breakthrough research paves the way for further exploration and adoption of TXA in the realm of orthopedic surgery.
Journal of Shoulder and Elbow Surgery
Effect of Tranexamic Acid on Shoulder Surgery: An Updated Meta-Analysis of Randomised Studies
Tze Khiang Tan et al.
Comments (0)